British Menopause Society tools for clinicians: Progestogens and endometrial protection
Authors:
- Haitham HamodaHHHaitham Hamoda
- On Behalf Of The Bms Medical Advisory CouncilOCOn Behalf Of The Bms Medical Advisory Council
Open Access
- 27 November 2021
- journal article
- review article
- Published by Taylor & Francis in Post Reproductive Health
- Vol. 28 (1) , 40-46
Abstract
Progestogen administration is required to oppose naturally produced or administered estrogens to provide endometrial protection. Within HRT regimens, this should be delivered for at least the same duration as that produced during the luteal phase of the monthly cycle and in the recommended doses to protect against the risk of endometrial hyperplasia and endometrial cancer. This includes progestogens administered for 12–14 days a month in sequential regimens and continuous daily intake in continuous combined HRT regimens. Shorter durations and lower doses of progestogen intake are likely to be associated with an increased risk of breakthrough bleeding, endometrial hyperplasia, and endometrial cancer.Keywords
This publication has 30 references indexed in Scilit:
- Hormone therapy in postmenopausal women and risk of endometrial hyperplasiaCochrane Database of Systematic Reviews, 2012
- Management of women requesting subtotal hysterectomyMenopause International, 2010
- Transdermal estradiol and oral or vaginal natural progesterone: bleeding patternsClimacteric, 2010
- Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancerAmerican Journal of Obstetrics and Gynecology, 2007
- Hormone replacement therapy in women with past history of endometriosisClimacteric, 2006
- Dose of progestin in postmenopausal-combined hormone therapy and risk of endometrial cancerAmerican Journal of Obstetrics and Gynecology, 2004
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Hormone replacement therapy after transcervical resection of the endometriumObstetrics & Gynecology, 1996
- A novel oestradiol-desogestrel preparation for hormone replacement therapy: Effects on hormones, lipids, bone, climacteric symptoms and endometriumMaturitas, 1993
- Dose dependent effects of oral progesterone on the oestrogenised postmenopausal endometrium.BMJ, 1983